期刊文献+

联用阿立哌唑对改善抗精神病药物所致高催乳激素血症的疗效 被引量:7

The effect of combined with aripiprazole to improve hyperprolactinemia caused by antipsychotic drugs
原文传递
导出
摘要 目的:探讨联用阿立哌唑对改善抗精神病药物所致高催乳激素血症的疗效及安全性。方法对70例服用其它单一抗精神病药物治疗且剂量固定4周以上精神分裂症患者,根据随机数字表法分为治疗组35例,对照组35例。治疗组在服用原药的基础上,每天联用阿立哌唑2.5 mg,对照组维持以前的药物治疗。两组均在治疗前及治疗第4周末分别测定患者血清催乳激素水平,并进行比较。同时用阳性和阴性症状量表(PANSS)评定临床症状程度,不良副反应量表(TESS)评定不良反应情况。结果治疗组患者血清催乳激素水平明显下降[(78.64±30.15)μg/L与(35.01±13.99)μg/L,t=9.585,P<0.05],对照组血清催乳激素水平无明显变化[(80.34±46.08)μg/L与(79.94±43.84)μg/L,t=0.084,P>0.05]。两组PANSS、TESS评分差异均无统计学意义(均P>0.05)。结论联用阿立哌唑对抗精神病药物所致高催乳激素血症有一定的治疗作用,并且相对安全。 Objective To investigate the efficacy and safety of combined with aripiprazole to improve hyper-prolactinemia caused by antipsychotic drugs.Methods 70 patients with schizophrenia who had been treated with antipsychotic drugs for 4 weeks prior to the study were divided into the two groups by random number table method:the treatment group(35 cases)were given each additionally 2.5 mg of aripiprazole oral,one time every day.The con-trol group (35 cases)continued with no extra management.The treatment group on the basis of the original drug administered daily in combination with aripiprazole 2.5mg,the control group maintained the previous drug treatment. Serum prolactin concentrations were assayed in patients of both groups before treatment and after 4 weeks treatment. At the same time,used the positive and negative symptom scale (PANSS)to assess the state of the clinical symptoms. The side effects were evaluated by Treatment Emergent Symptom Scale(TESS).Results After combined with aripi-prazole,it demonstrated that serum prolactin level in patients of the treatment group were significantly lowered [(78.64 ±30.15)μg/L vs (35.01 ±13.99)μg/L,t=9.585,P〈0.05],while those in patients of the control group had no change[(80.34 ±46.08)μg/L vs (79.94 ±43.84)μg/L,t=0.084,P〉0.05].There were no significant differences between the two groups of PANSS and TESS scores(all P〉0.05 ).Conclusion Combined with aripi-prazole for antipsychotic-induced hyperprolactinemia have a therapeutic effect and relatively safe.
出处 《中国基层医药》 CAS 2015年第8期1187-1189,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 阿立哌唑 精神治疗药物 精神分裂症 高催乳激素血症 Aripiprazole Psychotropic Drugs Schizophrenia Hyperprolactinemia
  • 相关文献

参考文献15

二级参考文献81

共引文献457

同被引文献76

  • 1吉中孚.多巴胺受体部分激动剂阿立哌唑药理作用与临床应用[J].中国新药杂志,2005,14(5):629-631. 被引量:31
  • 2徐乐平,纪菊英,施辉,瞿发林,张斌,邵亚琴,孙剑.阿立哌唑治疗抗精神病药物所致高催乳素血症对照研究[J].中国行为医学科学,2006,15(8):718-720. 被引量:51
  • 3张慧琴,冯云.高催乳素血症的临床表现及诊断[J].实用妇产科杂志,2007,23(2):69-71. 被引量:5
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5219
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2010:282.
  • 6舒良.精神分裂症防治指南[M].北京大学医学出版社,2007,38.
  • 7Burgener M, Aboulfadl H, Labat GC, et al. Peculiar orientational disorder in 4-bromo-4"-nitrobiphenyl (BNBP) and 4-bromo-4"-cy- anobiphenyl (BCNBP) leading to bipolar crystals [ J]. IUCrJ,3( Pt 3 ) :219-225. DOI : 10.1107/S2052252516006709.
  • 8Gurevich MI, Robinson CL. Medication-free Alternatives for Long- term Maintenance of Bipolar Disorder: A Case Series [J]. Glob Adv Health Med,4(2) :53-60.
  • 9Oedegaard K J, Alda M, Anand A, et al. The Pharmacogenomics of Bipolar Disorder study ( PGBD ) : identification of genes for lithi- um response in a prospective sample[ J]. BMC Psychiatry,2016, 16 ( 1 ) : 129. DOI : 10.1186/s12888-016-O732-x.
  • 10Ou X,Crane DE,Macintosh BJ,et al. CACNA1C rs1006737 gen- otype and bipolar disorder:Focus on intermediate phenotypes and cardiovascular comorbidity [ J ]. Neurosci Biobehav Rev, 2015, 55 : 198-210. DOI : 10. 1016/j. neubiorev. 2015.04. 022.

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部